220 Interleukin-6 in stable cystic fibrosis: an additional indicator of clinical disease activity?
| Autor: | Contreras-Bolívar, V., Olveira, C., Muñoz, A., Porras, N., Rubio-Martin, E., Doña, E., Doulatram, V.K., Tapia, M.J., Padin, S., Olveira, G. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis June 2017 16 Supplement 1:S118-S119 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect